Multiple Sclerosis

Three applications for the first generic capsules have been granted by the US Food and Drug Administration.

The RADIANCE phase 2 study showed the effectiveness of an investigational MS therapy vs placebo, so authors of the phase 3 SUNBEAM study compared the drug’s efficacy and safety with that of intramuscular...

The RADIANCE phase 2 study showed the effectiveness of an investigational MS therapy vs placebo, so authors of the phase 3 SUNBEAM study compared the drug’s efficacy and safety with that of intramuscular...

Authors of a new study analyzed whether an offspring’s risk of multiple sclerosis is impacted by the maternal Epstein–Barr virus IgG antibody levels.

The guidelines are an update to the 2002 American Academy of Neurology guidelines on immunization and multiple sclerosis.

This study assessed the clinical effectiveness of a home-based standing frame program for patients with progressive MS.

Authors of a new study determined whether there is an association between age at puberty onset and the risk for multiple sclerosis as well as the effect of BMI on that relationship.

It has been thought that the risk of postpartum relapses in multiple sclerosis is high. However, researchers of a study that will be presented at the AAN Annual Meeting determined whether the scientific...

In hopes of improving disease monitoring and treatment, researchers of a study presented at the ACTRIMS Forum evaluated vascular contributions to multiple sclerosis pathology.

As both the prevalence of obesity and the number of MS cases increases, researchers say it is important to examine the relationship between obesity in children and adolescents and the later occurrence of...